Cargando…
HDAC11: A novel inflammatory biomarker in Huntington’s disease
Autores principales: | Kumar, Vishal, Kaur, Simranjit, Kapil, Lakshay, Singh, Charan, Singh, Arti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149973/ https://www.ncbi.nlm.nih.gov/pubmed/35651655 http://dx.doi.org/10.17179/excli2022-4741 |
Ejemplares similares
-
Targeting N17 domain as a potential therapeutic target for the treatment of Huntington disease: An opinion
por: Kumar, Vishal, et al.
Publicado: (2021) -
Bipolar affective disorder in Huntington's disease: A neuropsychiatric perspective
por: Raj, Rajnish, et al.
Publicado: (2015) -
Upper facial chorea in Huntington disease
por: Fekete, Robert, et al.
Publicado: (2014) -
The impact of education, family income, and occupation on CD4 count among HIV infected adults
por: Maurya, Shesh Prakash, et al.
Publicado: (2020) -
Huntington’s Disease Presenting as Adult-Onset Parkinsonism
por: Kwak, In Hee, et al.
Publicado: (2022)